Liu Jie, Wang Ji-yao, Lu Ye
Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhonghua Nei Ke Za Zhi. 2006 Jun;45(6):475-7.
To evaluate the clinical value of serum fibrosis markers hyaluronic acid (HA), type IV collagen (CIV), type III procollagen N peptide (PIIIP) and laminin (LN) in the diagnosis of liver fibrosis.
Detection of the serum levels of these markers including HA, CIV, PIIIP, LN was carried out in 50 patients with chronic hepatitis B and 18 healthy persons. Liver biopsy was performed in all patients. The relationship between the markers and liver fibrosis stage was analyzed and the diagnostic value of the markers in liver fibrosis stage evaluated with receiver operating curve.
The correlation between serum HA, CIV, PIIIP and histologically assessed grade of inflammatory activity was weak (r = 0.430, 0.382 and 0.300, respectively, P < 0.05). The correlation between serum HA, CIV and histologically assessed stage of liver fibrosis were moderate (r = 0.614, 0.708, respectively, P < 0.05). The increase in serum HA, CIV was correlated with the progression of liver fibrosis. Based on receiver operating curve, the value of using serum HA to differentiate patients with early cirrhosis (S4) from those without cirrhosis (S0-S3) was greater than that of serum CIV, PIIIP and LN (the areas under the curves = 0.967 vs 0.932, 0.659, 0.403), while the ability of serum CIV to predict liver fibrosis (S1-S4) was superior to that of serum HA, PIIIP and LN (areas under the curves = 0.853 vs 0.680, 0.536, 0.487). Serum LN was found to show limited changes in different pathologic grade and stage. The combined detection of HA and CIV has higher specificity than that of a single marker.
Serum fibrosis markers can be helpful in diagnosis of liver fibrosis even in its early stage, but can not discriminate accurately the stage of fibrosis as accurately as the histological assessment. The combination of fibrosis markers is more valuable than single marker. New fibrosis markers and combination of noninvasive markers are the future trend in liver fibrosis research.
评估血清纤维化标志物透明质酸(HA)、IV型胶原(CIV)、III型前胶原N端肽(PIIIP)和层粘连蛋白(LN)在肝纤维化诊断中的临床价值。
对50例慢性乙型肝炎患者和18例健康人进行这些标志物(包括HA、CIV、PIIIP、LN)血清水平的检测。所有患者均进行肝活检。分析标志物与肝纤维化分期之间的关系,并采用受试者工作特征曲线评估标志物在肝纤维化分期中的诊断价值。
血清HA、CIV、PIIIP与组织学评估的炎症活动度之间的相关性较弱(r分别为0.430、0.382和0.300,P<0.05)。血清HA、CIV与组织学评估的肝纤维化分期之间的相关性为中等(r分别为0.614、0.708,P<0.05)。血清HA、CIV的升高与肝纤维化的进展相关。基于受试者工作特征曲线,血清HA用于区分早期肝硬化(S4)患者与无肝硬化(S0-S3)患者的价值大于血清CIV、PIIIP和LN(曲线下面积=0.967对0.932、0.659、0.403),而血清CIV预测肝纤维化(S1-S4)的能力优于血清HA、PIIIP和LN(曲线下面积=0.853对0.680、0.536、0.487)。发现血清LN在不同病理分级和分期中的变化有限。HA和CIV联合检测的特异性高于单一标志物。
血清纤维化标志物有助于肝纤维化的诊断,即使在早期阶段,但不能像组织学评估那样准确区分纤维化的阶段。纤维化标志物联合检测比单一标志物更有价值。新的纤维化标志物以及无创标志物的联合是肝纤维化研究的未来趋势。